Healthcare Business

fda_logo

5 Big FDA Decisions Expected in September

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, similar to that ...
Read Full Story »
generic drugs

How Amgen Can Disrupt the Market for Cholesterol Drugs

Amgen Inc. (NASDAQ: AMGN), known as a leading biotech in its field, made waves in the market on Friday morning. This biotech giant has the potential to disrupt the market ...
Read Full Story »
health care

Acelity Files for Initial Public Offering

Acelity Holdings Inc. has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). No terms were given in the filing, but ...
Read Full Story »
Biotechnology word cloud

Short Sellers Become More Focused in Major Biotechs

The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Pills

Short Sellers Have Mixed Feelings on Major Pharma

The short interest data have been released for the August 14 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
board room

Mylan Fires Back at Perrigo

Mylan N.V. (NASDAQ: MYL) announced Tuesday, in conjunction with the Irish Takeover Panel, that Perrigo Co. PLC (NYSE: PRGO) had made misleading statements to shareholders regarding Mylan’s offer to acquire ...
Read Full Story »
biotech

Nabriva Files for IPO

Nabriva Therapeutics has filed an amended F-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). No terms were given in the filing. The ...
Read Full Story »
Organovo 3D bioprinter

Mirna Therapeutics Files for IPO

Mirna Therapeutics Inc. has filed its paperwork with the Securities and Exchange Commission (SEC) to conduct an initial public offering (IPO) for its shares. The company has applied to list ...
Read Full Story »
Comfortable hospital bed

2 Positive Health Care REIT Views

Investors may still be able to find some upside in the health care sector, in the real estate investment trust (REIT) outfits. Physicians Realty Trust (NYSE: DOC) and Health Care ...
Read Full Story »
research

Epizyme Beats Out the Market With FDA Approval

Epizyme Inc. (NASDAQ: EPZM) survived the market carnage of what was Monday morning’s trading session. In fact this biopharma came out of the fray better off than when it went ...
Read Full Story »
145922793

HMS Runs on State of New York Contract

HMS Holdings Corp. (NASDAQ: HMSY) is winning in the market Monday despite all the turmoil and volatility that tanked the market earlier. Only recently did this company reported earnings at ...
Read Full Story »
generic drugs

FDA Grants Expanded Use of Promacta for Novartis

Novartis AG (NYSE: NVS) is one of the few companies with good news on a major market sell-off. Unfortunately, it is not big enough news to be moving the shares. ...
Read Full Story »
health care

How Relevant is Vital Therapies After Its Selloff?

Vital Therapies Inc. (NASDAQ: VTL) was last seen trading down 80% at $3.41 (versus $17.68 close) after it said that its Phase 3 trial in AILD (alcohol-induced liver decompensation) failed. ...
Read Full Story »
E000249

Pfizer Gets Approval For Hospira Acquisition

At a time when there is pressure on how large US companies are making domestic or overseas acquisitions are coming under more scrutiny, Pfizer Inc. (NYSE:PFE) announced on Monday that ...
Read Full Story »
rocket

What Lit a Fire Under These 3 Pharma Stocks

Over the past week, a few pharmaceutical companies made absolutely massive runs. In the past year, the health care sector was on fire from positive trials, U.S. Food and Drug ...
Read Full Story »